Skip to main content

Table 3 Summary of studies investigating the correlation between MIP and survival

From: Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature

Reference

Therapy Area/Population

Study Type

N

MIP and Survival

Correlation between MIP and survival

 Schmidt EP et al., 2006 [37]

ALS

Cohort study

95

MIP was an important predictor of 1-year survival (P < 0.05) after controlling for nonpulmonary factors known to predict survival in ALS

 Baumann F et al., 2010 [38]

ALS

Cohort study

80

MIP was significantly associated with survival (P < 0.05); survival time was increased in patients with normal MIP

 Gay PC et al., 1991 [39]

ALS

Prospective study

21

MIP was 100% sensitive for predicting 18-months survival (r = 0.57; P < 0.007)

 Chaudri MB et al., 2002 [40]

MND (ALS)

Single-center cohort study

53

Survivors had a higher percentage of predicted MIP than nonsurvivors (37.83 ± 24.32% vs 20.13 ± 18.43%; P < 0.01)

 Lopes Almeida JP, et al., 2012 [41]

ALS

Prospective, comparative study

60

There was a significant correlation between MIP and 5-years survival (P = 0.02) in patients with ALS using NIV

 Benzo R et al., 2013 [42]

COPD

Analysis of clinical data from NETT

1218

Decrease in MIP > 11 cm H2O was a predictor of 1-year mortality (OR, 2.19; P = 0.0217)

 Gray-Donald K et al., 1996 [43]

COPD

3 to 5-years follow-up of a double-blind RCT

348

Low MIP was a significant independent predictor of respiratory (HR, 0.64; 95% CI, 0.44–0.95) and all-cause mortality (HR, 0.67; 95% CI, 0.47–0.95)

 Schols AMWJ et al., 1998 [44]

COPD

RCT

203

Improvement in MIP during rehabilitation decreased the risk of death

 Hodgev VA et al., 2006 [45]

COPD

Prospective cohort study

63

A Cox proportional hazards analysis showed that MIP was a significant predictor of mortality (r = 0.91; 95% CI, 0.85–0.97; P = 0.005)

 Meyer FJ et al., 2001 [47]

Heart failure

Prospective study

244

In a univariate Cox regression analysis, MIP was found to be a significant prognostic indicator of survival (P = 0.001)

 Frankenstein L et al., 2009 [48]

Heart failure

Prospective, observational study

686

MIP was identified as a significant predictor of survival by univariate analysis; survivors had a significantly higher MIP and percentage of predicted MIP than nonsurvivors

 Ionescu AA et al., 1998 [49]

Cystic fibrosis

Single-center study

49

Mean % predicted MIP (SD) for survivors was 85.5% (28.4) compared with 64.1% (23.9) for nonsurvivors

 Marroni CA et al., 2014 [50]

Liver cirrhosis

Prospective cohort study

86

Sixty-two percent of patients with MIP < −70 cm H2O survived compared with 93% of patients with MIP > −70 cm H2O (P = 0.0001)

 Budweiser S et al., 2007 [46]

Chronic hypercapnic respiratory failure

Cohort study

464

MIP was a significant predictor of long-term survival; according to stepwise multivariate Cox regression analysis, P0.1/MIP was identified as an independent predictor of survival (P < 0.05)

 van der Palen J et al., 2004 [51]

Elderly with a mean age of 72.5 years

Cohort study

3839

Subjects in the lowest quintile of MIP had a 1.5-fold increased risk of cardiovascular-related death (HR, 1.54; 95% CI, 1.09–2.15) after adjustment for nonpulmonary function covariates

No correlation between MIP and survival

 Nizet TAC et al., 2005 [58]

Chronic hypercapnic COPD

Prospective, single-center study

47

No significant association

 Frankenstein L et al., 2008 [54]

CHF

Prospective, single-arm study

158

No significant association

 Habedank D et al., 2013 [55]

CHF

Single-center study

249

No significant association

 Hui D et al., 2014 [56]

Advanced cancer

Prospective, single-center study

222

No significant association

 White AC et al., 2005 [59]

Hematopoietic stem cell transplantation

Prospective observational study

56

No significant association

 Jackson M et al., 1994 [57]

Patients with a thoracoplasty for tuberculosis

Single-center study

32

No significant association

  1. ALS amyotrophic lateral sclerosis, CHF congestive heart failure, CI confidence interval, COPD chronic obstructive pulmonary disease, HR hazard ratio, MIP maximum inspiratory pressure, MND motor neurone disease, NETT National Emphysema Treatment Trial, NIV noninvasive ventilation, OR odds ratio, P 0.1 mouth occlusion pressure, RCT randomized controlled trial, SD standard deviation